Ledger.Open graph →
SEC Form D · filed December 20, 2023

Etheros Pharmaceuticals Corp

Offering
$300K
Sold
$300K
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
NASHVILLE, TN
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Laura W. Dugan · Nashville, TNDirectorJohn W. Scannell · Nashville, TNExec · DirectorFrancis W. Knuettel · Nashville, TNDirectorSubhasish W. Chakraborty · Nashville, TNExecMarc W. Feldmann · Nashville, TNDirectorJohn W. Scannell · Nashville, TNExec · DirectorSubhasish W. Chakraborty · Nashville, TNExecLaura W. Dugan · Nashville, TNDirectorMarc W. Feldmann · Nashville, TNDirectorFrancis W. Knuettel · Nashville, TNDirectorCD/BD Manager LLC · Troy, MIExecMaria B. Zondervan · Apopka, FLExec · DirectorAgne Miller · Grand Cayman, Cayman IslandsDirectorMichael Kamis · Calgary, British Columbia, CanadaDirectorShili Zhan · Fairfax, VADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗